New Research Poster Session 5

5.1

Overlap of DSM-IV Substance Use Disorders in US Adolescents: Implications for the National Comorbidity Survey Adolescent Supplement
Brady G. Case, M.D. Bradley Hospital, East Providence, RI
Richard T. Liu, PhD Alpert Medical School of Brown University, Providence, RI
Jian-ping He, MSC National Institute of Mental Health, Bethesda, MD
Kathleen R. Merikangas, Ph.D. National Institute of Mental Health, Bethesda, MD

5.2

Chronic Medical Conditons in Youth with Major Depressive Disorder
Aalamgeer Ibrahim, M.D., M.B.B.S. University of Texas Southwestern Medical Center, Dallas, TX
Jeylan Buyukdura, BS University of Texas Southwestern Medical Center at Dallas, Dallas, TX
Jessica King, BA Children's Health System of Texas, Dallas, TX
Taryn Mayes, M.S. University of Texas Southwestern Medical Center, Dallas, TX
Paul Nakonezny, PhD University of Texas Southwestern Medical Center at Dallas, Dallas, TX
Betsy Kennard, Psy.D. UT Southwestern Medical Center, Dallas, TX
Graham J. Emslie, M.D. UT Southwestern Medical Center at Dallas, Dallas, TX

5.3

Prevalence and Longitudinal Course of Anxiety Disorders in a Community-Based Sample of Children in South Carolina
Steven P. Cuffe, M.D. University of Florida College of Medicine- Jacksonville, Jacksonville, FL
Stephanie V. Sims, M.D. University of Florida College of Medicine-Jacksonville, Jacksonville, FL
Melissa Danielson, M.P.H. Centers for Disease Control and Prevention, Atlanta, GA
Gabriela T. DePrima, PsyD University of Florida College of Medicine- Jacksonville, Jacksonville, FL
Joseph Holbrook, D. Phil. Centers for Disease Control and Prevention, Atlanta, GA
Susanna Visser, M.S. Centers for Disease Control and Prevention, Atlanta, GA

5.4

Posttraumatic Stress Disorder (PTSD) in Children Exposed to the Earthquake/Tsunami in Chile
Marcela F. Abufhele, M.D. Cedars-Sinai, Los Angeles, CA
Ana Marina BriceÒo, MD Clinica Alemana, Santiago, Santiago Chile
Katerina Sommer, MD Clinica Alemana de Santiago-Chile, Santiago Chile

5.5

Differences in Predictors of Traditional and Cyber-Bullying: A Two-Year Longitudinal Study in Korean Schoolchildren
Su-Jin Yang, M.D. Chonnam National University Hospital, Kwangju Korea, Republic of (South)

5.6

The Stability of Parent-Reported Autistic Symptoms within the General Population
Akhgar Ghassabian, M.D. Erasmus Medical Center – Sophia Children's Hospital, Rotterdam Netherlands
Maartje Basten, MS , Rotterdam Netherlands
Frank C. Verhulst, M.D., Ph.D. Erasmus Medical Center – Sophia Children's Hospital, Rotterdam Netherlands
Vincent W. V. Jaddoe, MD, PhD Erasmus Medical Center–Sophia Children's Hospital, Rotterdam Netherlands
James Hudziak, M.D. Vermont Center For Children, Youth, & Families, Burlington, VT
Henning Tiemeier, M.D. Erasmus Medical Center – Sophia Children's Hospital, Rotterdam Netherlands

5.7

The Influence of Problematic Child-Teacher Relationships On Future Psychopathology in a Population Survey with Three-Year Follow up
Tamsin Ford, M.B.B.S., M.R.C.Psych., M.S., Ph.D. Peninsula Medical School, University of Exeter, Exeter United Kingdom
Iain Lang, DrPH, PhD Peninsula Medical School, University of Exeter, Exeter United Kingdom
Ruth Marlow, PsyD Peninsula Medical School, University of Exeter, Exeter United Kingdom
Howard Meltzer, PhD University of Leicester, Leicester United Kingdom
Robert Goodman, FRCPsych, MBBS, MSC, PhD Institute of Psychiatry, King's College London, London United Kingdom

5.8

Trajectories of Competence Among Puerto Rican Children
Ana Ortin New York State Psychiatric Institute and Columbia University, New York, NY
Cristiane S. Duarte, M.P.H., Ph.D. New York State Psychiatric Institute and Columbia University, New York, NY
Sa Shen, PhD Columbia University, New York, NY

5.9

Sex Differences in the Expression of Autism Spectrum Disorders in Children
Walter Zahorodny, PhD New Jersey Medical School- University of Medicine & Dentistry of New Jersey, Newark, NJ
Josephine Shenouda, M.S. New Jersey Medical School - University of Medicine & Dentistry of New Jersey, Newark, NJ

5.10

The Nature and Impact of Long-Term Psychotherapy with Adolescent Foster Youth
June M. Clausen, Ph.D. University of San Francisco, San Francisco, CA
Wanjiku Njoroge, M.D. University of Washington, Seattle, WA
Molly K. Saeger, MS A Home Within, San Francisco, CA

5.19

Effect of Cognitive Ability On the Safety Profile of Aripiprazole When Used to Treat Irritability Associated with Autistic Disorder
Alan Unis, M.D. Kootenai Medical Center, Coeur d'Alene, ID
Corey Ritchings, PharmD Bristol-Myers Squibb, Plainsboro, NJ
Kimberly K. Laubmeier, Ph.D. Otsuka America Pharmaceutical, Inc., Princeton, NJ
Ronald N. Marcus, MD Bristol-Myers Squibb, Wallingford, CT
Robert D. McQuade, PhD Otsuka Pharmaceutical Development and Commercialization, Inc., Princeton, NJ
James M. Eudicone, MBA, MS Bristol-Myers Squibb, Plainsboro, NJ
Raymond Mankoski, M.D., Ph.D. Bristol-Myers Squibb, Plainsboro, NJ

5.20

Clinical Trials On Pediatric Insomnia: Latest Trends
Jatinder M. Chawla, M.D. SUNY University Hospital of Brooklyn, Brooklyn, NY
Lenore Engel, M.D. SUNY- Downstate Medical Center, Brooklyn, NY
Aarti Gupta, MD , Houston, TX

5.21

OROS-Methylphenidate Effects on Neuropsychological and Functional Outcomes in Korean Children with ADHD: An Open-Label Study
Subin Park, M.D., Ph.D. Seoul National University College of Medicine, Seoul Korea, Republic of (South)
Jae-Won Kim, M.D., Ph.D. Seoul National University Hospital, Seoul Korea, Republic of (South)
Bung-Nyun Kim, MD, PhD Seoul National University College of Medicine, Seoul Korea, Republic of (South)
Min-Sup Shin, PhD Seoul National Univ. College of Medicine, Seoul, Korea Korea
Soo-Churl Cho, M.D., Ph.D. Seoul National University Hospital, Chongro-Gu Korea, Republic of (South)
Ji Hoon Kim, M.D., Ph.D. Pusan National University Hospital Children's Hospital, Yangsan-si Korea, Republic of (South)
Jungwoo Son, M.D. Chungbuk National University Hospital, Cheongju Korea, Republic of (South)

5.22

Asenapine Pharmacokinetics and Tolerability in a Pediatric Population with a Psychotic Disorder: Influence of Dosing Regimen
Peter Dogterom, Ph.D. Merck Sharp & Dohme, Oss Netherlands
Robert A. Riesenberg, MD Atlanta Center for Medical Research, Atlanta, GA
Michael Lesem, MD Claghorn-Lesem Research Clinic, Houston, TX
Rik de Greef, MSc Merck & Co., Inc., Kenilworth, NJ
AndrÈ Miltenburg, PhD Merck Sharp & Dohme, Oss Netherlands
Ronald Landbloom, MD Merck & Co., Inc., Whitehouse Station, NJ
Matthew D. Troyer, MD Merck & Co., Inc., North Wales, PA

5.23

Health-related Quality of Life and Functional Outcomes from a Randomized-withdrawal Study of Long-term Lisdexamfetamine Dimesylate Treatment in Children and Adolescents with ADHD
Liza A. Squires, M.D. Shire Development LLC, Wayne, PA
Tobias Banaschewski, M.D., Ph.D. Department of Child and Adolescent Psychiatry, Mannheim Germany
Michel Lecendreux, M.D. Hôpital Robert Debré, Paris France
Mats Johnson, M.D. Child Neuropsychiatry Unit, Göteborg Sweden
Alessandro Zuddas, M.D. University of Cagliari, Cagliari Italy
Paul Hodgkins, M.S.C., Ph.D. Shire Development LLC, Wayne, PA
Ralph Bloomfield, MSC Shire Pharmaceuticals, Inc., Basingstoke United Kingdom
David Coghill, M.D., F.R.C.Psych., MBChB Ninewells Hospital, Dundee Scotland

5.24

Weight Changes Associated with Atypical Antipsychotics
Ami S. Baxi, M.D. SUNY at Stony Brook, Stony Brook, NY
Mandana Torabi, M.D. Stony Brook University, Smithtown, NY
Gabrielle A. Carlson, MD Stony Brook University, Stony Brook, NY

5.25

Maintenance of Efficacy of Lisdexamfetamine Dimesylate: Results From Two Randomized-Withdrawal Studies in Adults and in Children and Adolescents with ADHD
Liza A. Squires, M.D. Shire Development LLC, Wayne, PA
Maria Gasior, M.D., Ph.D. Shire Development LLC, Wayne, PA
Tobias Banaschewski, M.D., Ph.D. Department of Child and Adolescent Psychiatry, Mannheim Germany
Mats Johnson, M.D. Child Neuropsychiatry Unit, Göteborg Sweden
Alessandro Zuddas, M.D. University of Cagliari, Cagliari Italy
Michel Lecendreux, M.D. Hôpital Robert Debré, Paris France
Ralph Bloomfield, MSC Shire Pharmaceuticals, Inc., Basingstoke United Kingdom
David Coghill, M.D., F.R.C.Psych., MBChB Ninewells Hospital, Dundee Scotland

5.26

Psychiatric Polypharmacy Among Children: Impact of a Quality Improvement Initiative
Jennifer P. Wisdom, MPH, PhD , New York, NY
Emily Leckman-Westin, PhD New York State Office of Mental Health, Albany, NY
Ka Ho Brian Chor, PhD Columbia University, New York, NY
Sa Shen, PhD Columbia University, New York, NY
Qingxian Chen, MS New York State Office of Mental Health, Albany, NY
Bradley Stein, M.D., M.P.H., Ph.D. RAND, Pittsburgh, PA
Mark Olfson, MD, MPH Columbia University, New York State Psychiatric Institute, Brooklyn, NY
Molly Finnerty, MD New York State Office of Mental Health, Albany, NY
Kimberly Hoagwood, Ph.D. Columbia University, New York, NY

5.27

Safety and Efficacy of Aripiprazole in the Long-Term Maintenance Treatment of Pediatric Patients with Irritability Associated with Autistic Disorder
Robert Findling, M.D., M.B.A. University Hospitals Case Medical Center, Cleveland, OH
Karen Timko, MBA Bristol-Myers Squibb, Wallingford, CT
Katherine Lears, BA Bristol-Myers Squibb, Wallingford, CT
Theresa McCartney, BSN, MA Bristol-Myers Squibb, Lawrenceville, NJ
Robert D. McQuade, PhD Otsuka Pharmaceutical Development and Commercialization, Inc., Princeton, NJ
Ronald N. Marcus, MD Bristol-Myers Squibb, Wallingford, CT
Raymond Mankoski, M.D., Ph.D. Bristol-Myers Squibb, Plainsboro, NJ

5.28

References: N-Acetylcysteine in the Treatment of Pediatric Trichotillomania: Randomized, Double-Blind, Placebo-Controlled Trial
Michael Bloch, M.D. Yale University School of Medicine, New Haven, CT
Kaitlyn Panza, B.A. Yale University, New Haven, CT
Christopher Pittenger, MD, PhD Yale University, New Haven, CT
James Leckman, M.D. Yale Child Study Center, New Haven, CT

5.29

Functional Analysis of Rare Genetic Variants in Autism Using a Zebrafish Model System
Ellen Hoffman, M.D. Yale University School of Medicine, New Haven, CT
Antonio J. Giraldez, PhD Yale University, New Haven, CT
Matthew W. State, M.D., Ph.D. Yale Child Study Center, New Haven, CT

5.30

The Role of Glucocorticoids in the Impact of Prenatal Stress On Neuronal Progenitors and Transcription Factors Involved in Gabaergic Cell Development
Hanna Stevens, M.D., Ph.D. Yale Child Study Center, New Haven, CT
Flora M. Vaccarino, MD Yale School of Medicine, New Haven, CT

5.32

Genetic Variation in Dopaminergic and Adrenergic Systems Moderates Treatment Response to Methylphenidate and Guanfacine in Children and Adolescents with ADHD
Erika Nurmi, M.D., Ph.D. University of California, Los Angeles, Los Angeles, CA
Karyn S. Mallya, BA University of California, Los Angeles, Los Angeles, CA
James McGough, M.D. UCLA Semel Institute for Neuroscience & Human Behavior, Los Angeles, CA
Sandra K. Loo, Ph.D. University of California, Los Angeles, Los Angeles, CA
Robert M. Bilder, PhD Semel Institute for Neuroscience & Human Behavior, Los Angeles, CA
Fiona Whelan, MS University of California, Los Angeles, Los Angeles, CA
James T. McCracken, M.D. UCLA Semel Institute of Neuroscience and Human Behavior, Los Angeles, CA

5.33

Atomoxetine Affects Synaptic Composition in Rodents in an Age-Dependent Manner
Patrick T. Udvardi, M.S. University of Ulm, Ulm Germany
Karl Fˆhr, PhD University of Ulm, Ulm Germany
Jens Dreyhaupt University of Ulm, Ulm Germany
Joerg M. Fegert, M.D., Ph.D. University of Ulm, Ulm Germany
Tobias M. Boeckers, MD University of Ulm, Ulm Germany
Andrea G. Ludolph, M.D. University of Ulm, Ulm Germany

5.34

DAT1 3'UTR VNTR Genotype, Genetic Ancestry, and Response to Dexmethylphenidate
Mark A. Stein, Ph.D. University of Illinois at Chicago, Chicago, IL
Irwin Waldman, PhD Emory University,Psychology Dept.,, Atlanta, GA
Jeffrey Newcorn, F.R.C.P. Mt. Sinai Medical Center, New York, NY
Jeffrey R. Bishop, PharmD University of Illinois at Chicago, Chicago, IL
Rick Kittles, PhD University of Illinois at Chicago, Chicago, IL
Edwin H. Cook, M.D. University of Illinois at Chicago, Chicago, IL

5.35

A Project to Identify Genes Contributing to Autism in Consanguineous Egyptian Pedigrees by Utilizing Homozygosity Mapping and Whole-Exome Sequencing
Paul El-Fishawy, M.D., J.D. Yale University, New Haven, CT
Rehab Khalil, MD National Research Center, Dokki, Cairo Egypt
Stephan Sanders, MD Yale University, New Haven, CT
A. Gulhan Ercan-Sencicek, PhD Yale University, New Haven, CT
Abha Gupta, M.D. Yale University, New Haven, CT
Adel Hashish, PhD National Research Center, Dokki, Cairo Egypt
Heba Habib, MD National Research Center, Dokki, Cairo Egypt
Kaya Bilguvar, MD Yale University, New Haven, CT
Murim Choi, PhD Yale University, New Haven, CT
Nagwa Abdel Meguid, MD National Research Center, Dokki, Cairo Egypt
Matthew W. State, M.D., Ph.D. Yale Child Study Center, New Haven, CT

5.36

High Psychiatric Comorbidity in Adolescents with Dissociative Disorders: A Non-Western Sample From Turkey
Tuba Duzman Mutluer, MD Istanbul University, Istanbul Medical Faculty, Istanbul Turkey
Hasan Bozkurt, M.D. Istanbul University, Istanbul Medical Faculty, Istanbul Turkey
Cigdem Kose, M.S. Istanbul University, Istanbul Turkey
Salih Zoroglu, M.D. Istanbul University, Istanbul Medical Faculty, Istanbul Turkey

5.37

Aripiprazole in Children and Adolescents with Conduct Disorder: A Single-Center, Open-Label Study
Ey¸p Sabri Ercan, MD , Istanbul Turkey
Elif Ercan, PhD Ege University, Izmir Turkey
Taciser Uysal, MD Ege University, Izmir Turkey
ulku Akyol Ardic, MD Ege University School of Medicine, Izmir Turkey

5.38

Trends in Psychotropic Medication Use Among Medicaid Enrolled Preschoolers
Cynthia Fontanella, Ph.D. The Ohio State University, Columbus, OH
Danielle Hiance, M.S.W. The Ohio State University, Columbus, OH
Gary Phillips, MAS The Ohio State University, Columbus, OH
Jeffrey Bridge, PhD The Research Institute at Nationwide Children's Hospital, Columbus, OH
John V. Campo, M.D. The Ohio State University, Columbus, OH

5.39

Iron Status in Children and Adolescents Following Extended Risperidone Treatment
Chadi A. Calarge, M.D. The Univ. of Iowa Carver College of Medicine, Iowa City, IA
Ekhard E. Ziegler, MD University of Iowa, Iowa, IA

5.40

Pharmacotherapy in Children with Autism Spectrum Disorder
Josephine Shenouda, M.S. New Jersey Medical School - University of Medicine & Dentistry of New Jersey, Newark, NJ
Danielle Rosivack, MD New Jersey Medical School- University of Medicine & Dentistry of New Jersey, Newark, NJ
Rita Baltus, MD New Jersey Medical School- University of Medicine & Dentistry of New Jersey, Newark, NJ
Kiranmai VSN Yarlagadda, MD New Jersey Medical School- University of Medicine & Dentistry of New Jersey, Newark, NJ
Walter Zahorodny, PhD New Jersey Medical School- University of Medicine & Dentistry of New Jersey, Newark, NJ

5.42

Aripiprazole for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients: Insight Into the Emergence and Resolution of Adverse Events
Raun Melmed, M.D. Melmed Center, Southwest Autsim Research and Resource Center, Scottsdale, AZ
Samantha Min, M.B.A., Pharm.D. Otsuka Pharmaceutical Development and Commercialization, Inc., Carlsbad, CA
Jessie Chambers, PhD Otsuka Pharmaceutical Development and Commercialization, Inc., Albuquerque, NM
Sabrina V. Marler, MS Bristol-Myers Squibb, Wallingford, CT
Ronald N. Marcus, MD Bristol-Myers Squibb, Wallingford, CT
Robert D. McQuade, PhD Otsuka Pharmaceutical Development and Commercialization, Inc., Princeton, NJ
Raymond Mankoski, M.D., Ph.D. Bristol-Myers Squibb, Plainsboro, NJ

5.43

Trends in Atypical Antipsychotic Medication Prescribed to Children Aged 6 Years or Less On Medicaid in Kentucky
William Lohr, M.D. University of Louisville, Louisville, KY
Russell T. Chowning, MD University of Louisville, Louisvlle, KY
Michelle Stevenson, MD University of Louisville, Louisville, KY
Patricia G. Williams, MD University of Louisville, Louisville, KY

5.44

Aggression Subtype, Callous-Unemotional Traits, and Pharmacotherapy Outcomes of Children with ADHD Treated for Aggressive Behavior
Joseph C. Blader, Ph.D. Stony Brook State University of New York, Stony Brook, NY
Steven R. Pliszka, M.D. The University of Texas Health Science Center at San Antonio, San Antonio, TX
Vivian Kafantaris, M.D. The Zucker Hillside Hospital, Glen Oaks, NY

5.45

Non-Fatal Cardiovascular Adverse Effects of Stimulant Treatment in Children with ADHD
Soren Dalsgaard, M.D., Ph.D. University of Southern Denmark, Odense Denmark
Anette P. Kvist, MSC Business and Social Sciences, Aarhus University, Aarhus Denmark
James Leckman, M.D. Yale Child Study Center, New Haven, CT
Helena S. Nielsen, PhD Business and Social Sciences, Aarhus University, Aarhus Denmark
Marianne Simonsen, PhD Business and Social Sciences, Aarhus University, Aarhus Denmark

5.46

The Effect of Methylphenidate On Seizure in Subjects with ADHD and Epilepsy
Jangho Park, M.D. University of Ulsan College of Medicine, Asan Medical Center, Seoul Korea, Republic of (South)
Hyo-Won Kim, M.D., Ph.D. University of Ulsan College of Medicine, Asan Medical Center, Seoul Korea, Republic of (South)
Hae-won Choi, MD University of Ulsan College of Medicine, Asan Medical Center, Seoul Korea, Republic of (South)
Tae-Sung Ko, MD, PhD University of Ulsan College of Medicine, Asan Medical Center, Seoul Korea, Republic of (South)
Mi-Sun Yum, MD, PhD University of Ulsan College of Medicine, Asan Medical Center, Seoul Korea, Republic of (South)

5.47

A Latent Class Analysis of the Parent Drug Attitude Inventory
Lisa Townsend, Ph.D. Rutgers University, New Brunswick, NJ

5.48

Analysis of Body Mass Index Change in Persons with Autism Spectrum Disorders:Comparison of Treatment with Risperidone and Aripiprazole
Logan K. Wink, M.D. Indiana University School of Medicine, Indianapolis, IN
Maureen Early , Princeton, NJ
Amy Pottenger, BA Indiana University School of Medicine, Indianapolis, IN
Robert Bermingham, BA Indiana University School of Medicine, Indianapolis, IN
Christopher McDougle, M.D. Harvard Medical School, Lexington, MA
Craig Erickson, M.D. Indiana University School of Medicine, Indianapolis, IN

5.49

Psychotropic Medication Patterns in a Residential Program for Youth
Jonathan Huefner, Ph.D. Boys Town, Boys Town, NE

5.50

The Characteristics and Treatment Needs of Younger Versus Older Youth in an Intensive Residential Treatment Program
Jonathan Huefner, Ph.D. Boys Town, Boys Town, NE
Dennis G. Vollmer, MS Boys Town National Research Hospital, Omaha, NE

5.51

What Are the Challenges and Difficulties Only Children and Their Parents Encounter? A Comparison of Socio-Emotional Characteristics and Parental Factors of Only Children and Children with Sibling
Jeong Y. Kim, M.D. Hanyang University Seoul Hospital, Seoul Korea, Republic of (South)
Hyun Y. Oh, MD Hanyang University Seoul Hospital, Seoul Korea, Republic of (South)
Dong H. Ahn, MD, PhD Hanyang University Hospital, Seoul Korea, Republic of (South)
Byung-Ju Hwang, MD Motherth Hospital, Ulsan Korea, Republic of (South)

5.52

Building Resilience to Youth's Involvement in Violent Extremism Among Somali-Americans in Minneapolis-St. Paul
Stevan Weine, MD University of Illinois at Chicago, Chicago, IL
Osman Ahmed, BS University of Illinois at Chicago, Chicago, IL
Ivana Brajkovic, B.A. University of Illinois at Chicago, Chicago, IL

5.53

The Co-Existence of Underlying Medical Illnesses in Pediatric and Adolescent Inpatients Presenting with Somatoform Disorders
Natalia Ramos, M.D., M.P.H. University of California, Los Angeles and San Fernando Valley Psychiatry Training Program, Sepulveda, CA
Susan Turkel, M.D. Children's Hospital Los Angeles, Los Angeles, CA
Julienne Jacobson, M.D. USC, Los Angeles, CA

5.54

Empirical Ethics Analysis: Data Describing Participants' Perspectives On Return of Individual Genomic Research Results and Disclosure of Conflicts of Interest
Marilyn E. Coors, PhD , Aurora, CO
Susan K. Mikulich-Gilbertson, Ph.D. University of Colorado Anschutz Medical Campus, Aurora, CO
Kristen M. Raymond, BS University of Colorado Anschutz Medical Campus, Aurora, CO
Shannon K. McWilliams, BS University of Colorado Anschutz Medical Campus, Aurora, CO
Christian J. Hopfer, M.D. University of Colorado School of Medicine, Aurora, CO

5.55

Short-Term Effects of Child Maltreatment On Mental Health: A Study On Children and Adolescents Who Suffered Different Forms of Abuse
Paola De Rose, DrPH , Rome Italy
Flavia Cirillo, PsyD Children's Hospital Bambino Gesù, Rome Italy
Francesco Demaria, MD Children's Hospital Bambino Gesù, Rome Italy
Fortunata Salvaguardia, PsyD Children's Hospital Bambino Gesù, Rome Italy
Paola Bergonzini, PsyD Children's Hospital Bambino Gesù, Rome Italy
Maria Pia Casini, MD , Rome Italy
Stefano Vicari, M.D. IRCCS Ospedale Pediatrico Bambino Gesù, Roma Italy

5.56

Correlation Between Intellectual Functioning and Inattention, Hyperactivity, and Oppositional Symptoms in Brazilian Maltreated Adolescents
Paula Approbato Oliveira, MS Medical School, University of Sao Paulo, São Paulo Brazil
Giovanna Kliemann Scarpari, MS Medical School, University of São Paulo, São Paulo Brazil
Paulo Jannuzzi Cunha, PhD Medical School, University of Sao Paulo, São Paulo Brazil
Bernardo dos Santos, BS University of Sao Paulo, São Paulo Brazil
Sandra Scivoletto, PhD School of Medicine, University of São Paulo, São Paulo Brazil

5.57

Parenting Outcomes and Parental Social Cognitive Processes: The Moderating Role of Child Behavior
Kathryn R. Hesmond, B.S. Northwestern University, Chicago, IL
Hannah Chapel, B.A. Northwestern University, Chicago, IL
Carri Hill, Ph.D. Northwestern University, Oak Park, IL

5.58

Why the Prevalence of Mental Disorders in Children in Situations of Institutional Protection Is So High?
Antonio Pelaz Sr., M.D. Hospital Clinico San Carlos, Madrid Spain
Prudencio Rodriguez-Ramos Sr., M.D. Hospital La Paz, Madrid Spain
Jose Maria Gonzalez Sr., MD Hospital La Paz, Madrid Spain

5.59

Aftermath of Child Sexual Abuse: 3-Year Data From Nation-Funded Sexual Violence Victim Protection Center for Children Under 13 in Korea
Dong-Ho Song, MD, PhD Yosei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul Korea, Republic of (South)
Soo Young Lee, MD Yonsei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul Korea, Republic of (South)
Tae-Kyoung Kim, PhD BaekSok University, Seoul Korea, Republic of (South)
Keun-Ah Cheon, M.D., Ph.D. Yosei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul Korea, Republic of (South)
Sun Young Kim, MD Yonsei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul Korea, Republic of (South)
Sodahm Kook, MD , Seoul Korea, Rebublic Of
Woo Young Im, M.D. Yosei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul Korea, Republic of (South)

5.60

Different Developmental Passages Would Influence On the Psychiatric Features of Korean Children with Sexual Abuse
Dong-Ho Song, MD, PhD Yosei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul Korea, Republic of (South)
Soo Young Lee, MD Yonsei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul Korea, Republic of (South)
Tae-Kyoung Kim, PhD BaekSok University, Seoul Korea, Republic of (South)
Keun-Ah Cheon, M.D., Ph.D. Yosei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul Korea, Republic of (South)
Sun Young Kim, MD Yonsei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul Korea, Republic of (South)
Sodahm Kook, MD , Seoul Korea, Rebublic Of
Woo Young Im, M.D. Yosei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul Korea, Republic of (South)

5.61

Prenatal Maternal Depression Is Associated with Low Birth Weight and Shorter Gestational Age
Sunhwa Lee, MD , Seoul Korea, Republic of (South)
Hyoung-Yoon Chang, M.D. Yonsei University College of Medicine, Seoul Korea, Republic of (South)
Yee Jin Shin, M.D., Ph.D. Gangnam Severance Hospital, Seoul Korea, Republic of (South)

5.62

Effect of Early Stimulation on Language Development of Economically Disadvantaged Indian Children
Prahbhjot Malhi, Ph.D. Post Graduate Institute of Medical Education and Research, Chandigarh India
Manjit Sidhu, Ph.D. Research Assistant, Chandigarh India
Bhavneet Bharti, MD Postgraduate Institute of Medical Education and Research, Chandigarh India

5.63

Impact of Multiple Risk Factors On the Development Profile of Indian Children
Manjit Sidhu, Ph.D. Research Assistant, Chandigarh India
Prahbhjot Malhi, Ph.D. Post Graduate Institute of Medical Education and Research, Chandigarh India
Jagat Jerath, PhD Professor (Retd.), Chandigarh India

5.64

Maternal Risk Factors and Mother-Child Play in Latino Immigrant Head Start Families
Helena Duch, Psy.D. Columbia University, New York, NY
Maria Marti, M.S. Columbia University and New York State Psychiatric Institute, New York, NY
Saskia Op den Bosch, BS Columbia University, New York, NY
Marta Font, MS Columbia University, New York, NY